摘要
Autophagy plays an essential role in maintaining an intricate balance between nutrient demands and energetic requirements during normal homeostasis. Autophagy recycles metabolic substrates from nonspecific bulk degradation of proteins and excess or damaged organelles. Recent work posits an active and dynamic signaling role for extracellular matrix-evoked autophagic regulation, that is, allosteric and independent of prevailing nutrient conditions. Several candidates, representing a diverse repertoire of matrix constituents (decorin, collagen VI, laminin α2, endostatin, endorepellin, and kringle V), can modulate autophagic signaling pathways. Importantly, a novel principle indicates that matrix constituents can differentially modulate autophagic induction and repression via interaction with specific receptors. Most of the matrix-derived factors described here appear to control autophagy in a canonical manner but independent of nutrient deprivation. Because the molecular composition and structure of the extracellular matrix are dynamically remodeled during various physiological and pathological conditions, we propose that matrix-regulated autophagy is key for maintaining proper tissue homeostasis and disease prevention, such as cancer progression and muscular dystrophies. Autophagy plays an essential role in maintaining an intricate balance between nutrient demands and energetic requirements during normal homeostasis. Autophagy recycles metabolic substrates from nonspecific bulk degradation of proteins and excess or damaged organelles. Recent work posits an active and dynamic signaling role for extracellular matrix-evoked autophagic regulation, that is, allosteric and independent of prevailing nutrient conditions. Several candidates, representing a diverse repertoire of matrix constituents (decorin, collagen VI, laminin α2, endostatin, endorepellin, and kringle V), can modulate autophagic signaling pathways. Importantly, a novel principle indicates that matrix constituents can differentially modulate autophagic induction and repression via interaction with specific receptors. Most of the matrix-derived factors described here appear to control autophagy in a canonical manner but independent of nutrient deprivation. Because the molecular composition and structure of the extracellular matrix are dynamically remodeled during various physiological and pathological conditions, we propose that matrix-regulated autophagy is key for maintaining proper tissue homeostasis and disease prevention, such as cancer progression and muscular dystrophies. CME Accreditation Statement: This activity ("ASIP 2014 AJP CME Program in Pathogenesis") has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity ("ASIP 2014 AJP CME Program in Pathogenesis") for a maximum of 48 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.CME Disclosures: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose. Macroautophagy (hereafter known as autophagy) is a catabolic process that nonselectively degrades bulk cytosolic components, proteins, and organelles, recycling liberated nutrients for the synthesis of new macromolecules.1Mizushima N. Komatsu M. Autophagy: renovation of cells and tissues.Cell. 2011; 147: 728-741Abstract Full Text Full Text PDF PubMed Scopus (3822) Google Scholar, 2Wang K. Klionsky D.J. Mitochondria removal by autophagy.Autophagy. 2011; 7: 297-300Crossref PubMed Scopus (310) Google Scholar Autophagic induction occurs via the reduced availability of nutrients. Intrinsically, autophagic initiation is a tightly coordinated and regulated process, involving the suppression of nascent peptide synthesis [via suppression of phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) arm] and activation of the forkhead box subclass O3 (FoxO3) transcription factor that promotes recruitment of Vps34, a class III PI3K, to beclin 1-positive complexes.3Zhao J. Brault J.J. Schild A. Cao P. Sandri M. Schiaffino S. Lecker S.H. Goldberg A.L. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.Cell Metab. 2007; 6: 472-483Abstract Full Text Full Text PDF PubMed Scopus (1131) Google Scholar, 4Funderburk S.F. Wang Q.J. Yue Z. The Beclin 1-VPS34 complex–at the crossroads of autophagy and beyond.Trends Cell Biol. 2010; 20: 355-362Abstract Full Text Full Text PDF PubMed Scopus (588) Google Scholar Autophagy is linked to prevailing energetic demands, overall cellular metabolome, and cell growth programs. The modulation of autophagy is emerging as a frontrunner in curtailing several diseases, including tumorigenesis5Koren I. Kimchi A. Cell biology. Promoting tumorigenesis by suppressing autophagy.Science. 2012; 338: 889-890Crossref PubMed Scopus (37) Google Scholar and muscular dystrophies.6Grumati P. Bonaldo P. Autophagy in skeletal muscle homeostasis and in muscular dystrophies.Cells. 2012; 1: 325-345Crossref PubMed Scopus (58) Google Scholar The classification of autophagy as a tumor suppressive entity7Liang J. Mills G.B. AMPK: a contextual oncogene or tumor suppressor?.Cancer Res. 2013; 73: 2929-2935Crossref PubMed Scopus (193) Google Scholar, 8Komatsu M. Ichimura Y. Physiological significance of selective degradation of p62 by autophagy.FEBS Lett. 2010; 584: 1374-1378Abstract Full Text Full Text PDF PubMed Scopus (413) Google Scholar further aligns with the amply documented function of soluble matrix constituents, such as decorin and endostatin, as oncostatic and angiostatic effectors.9Iozzo R.V. Sanderson R.D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.J Cell Mol Med. 2011; 15: 1013-1031Crossref PubMed Scopus (396) Google Scholar, 10Neill T. Schaefer L. Iozzo R.V. Decorin: a guardian from the matrix.Am J Pathol. 2012; 181: 380-387Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar Moreover, autophagy is gaining acceptance as a necessary prerequisite in maintaining tissue integrity and overall organismal homeostasis.11Mizushima N. Yoshimori T. Levine B. Methods in mammalian autophagy research.Cell. 2010; 140: 313-326Abstract Full Text Full Text PDF PubMed Scopus (3495) Google Scholar, 12Choi A.M.K. Ryter S.W. Levine B. Autophagy in human health and disease.N Engl J Med. 2013; 368: 651-662Crossref PubMed Scopus (983) Google Scholar, 13Rubinsztein D.C. Codogno P. Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases.Nat Rev Drug Discov. 2012; 11: 709-730Crossref PubMed Scopus (1117) Google Scholar Aberrant autophagy, defined by either inadequate levels or hyperactive autophagic flux, is detrimental for normal tissue function and manifests as neurological disorders such as Parkinson disease14Dagda R. Cherra 3rd, S.J. Kulich S.M. Tandon A. Park D. Chu C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission.J Biol Chem. 2009; 284: 13843-13855Crossref PubMed Scopus (740) Google Scholar or congenital myopathies.6Grumati P. Bonaldo P. Autophagy in skeletal muscle homeostasis and in muscular dystrophies.Cells. 2012; 1: 325-345Crossref PubMed Scopus (58) Google Scholar Matrix-derived signals transduced from receptor engagement converge on a common core of autophagic machinery in a variety of tissues and specialized microenvironments and are necessary for germane biological phenotypes. A diverse collection of matrix constituents, including decorin, collagen VI, laminin α2, endostatin, endorepellin, and kringle V, are rapidly emerging as regulators of autophagy that are seemingly independent of the predominant nutrient concentrations. Although the concept of extracellular matrix (ECM) regulation of autophagy has been discussed before,15Lock R. Debnath J. Extracellular matrix regulation of autophagy.Curr Opin Cell Biol. 2008; 20: 583-588Crossref PubMed Scopus (131) Google Scholar most of the previous studies focused on how detachment from the matrix (anoikis) would trigger autophagy, primarily through an integrin-mediated mechanism. In this review, we focus on soluble, matrix-derived products with an intrinsic ability to modulate catabolic metabolism. We propose that the ECM is a functional repository of autocrine and paracrine factors that dynamically modulate, couple, and wield autophagy as a potent tumor suppressor and function prominently in the prevention of several complex pathological states. Decorin, with the proposed title of guardian from the matrix, is a pan-receptor tyrosine kinase (RTK) inhibitor for tumorigenic and angiogenic suppression.10Neill T. Schaefer L. Iozzo R.V. Decorin: a guardian from the matrix.Am J Pathol. 2012; 181: 380-387Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar, 16Schaefer L. Iozzo R.V. Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation.Curr Opin Genet Dev. 2012; 22: 56-57Crossref PubMed Scopus (73) Google Scholar It binds RTK members via its protein core, concurrently elicits degradation, and attenuates downstream signaling.10Neill T. Schaefer L. Iozzo R.V. Decorin: a guardian from the matrix.Am J Pathol. 2012; 181: 380-387Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar Decorin suppresses critical oncogenes (β-catenin, Myc, and hypoxia inducible factor-1α) and simultaneously induces tumor suppressor genes (p21, thrombospondin-1, and mitostatin) that oppose oncogenesis and angiogenesis.17Neill T. Painter H. Buraschi S. Owens R.T. Lisanti M.P. Schaefer L. Iozzo R.V. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor-1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.J Biol Chem. 2012; 287: 5492-5506Crossref PubMed Scopus (131) Google Scholar, 18Neill T. Jones H.R. Crane-Smith Z. Owens R.T. Schaefer L. Iozzo R.V. Decorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1.FEBS J. 2013; 280: 2353-2368Crossref PubMed Scopus (42) Google Scholar Moreover, decorin coordinates a pro-inflammatory cascade function in sepsis and tumorigenesis.19Merline R. Moreth K. Beckmann J. Nastase M.V. Zeng-Brouwers J. Tralhão J.G. Lemarchand P. Pfeilschifter J. Schaefer R.M. Iozzo R.V. Schaefer L. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21.Sci Signal. 2011; 4: ra75Crossref PubMed Scopus (245) Google Scholar A paradigm shift has occurred about the bioactivity of decorin after high-resolution transcriptome profiling of the tumor microenvironment.20Buraschi S. Neill T. Owens R.T. Iniguez L.A. Purkins G. Vadigepalli R. Evans B. Schaefer L. Peiper S.C. Wang Z.X. Iozzo R.V. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.PLoS One. 2012; 7: e45559Crossref PubMed Scopus (73) Google Scholar Systemically administered decorin evokes a stromal-specific gene signature. Among the small subset of induced genes, decorin stimulates the expression of a putative tumor suppressor gene Peg3.20Buraschi S. Neill T. Owens R.T. Iniguez L.A. Purkins G. Vadigepalli R. Evans B. Schaefer L. Peiper S.C. Wang Z.X. Iozzo R.V. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.PLoS One. 2012; 7: e45559Crossref PubMed Scopus (73) Google Scholar By exploiting the genomically stable nature of endothelial cells as a surrogate for a crucial component of the tumor microenvironment, paternally expressed 3 (Peg3) immunostaining with established autophagic markers has indicated the formation of subcellular structures reminiscent of autophagosomes.21Buraschi S. Neill T. Goyal A. Poluzzi C. Smythies J. Owens R.T. Schaefer L. Torres A.T. Iozzo R.V. Decorin causes autophagy in endothelial cells via Peg3.Proc Natl Acad Sci U S A. 2013; 110: E2582-E2591Crossref PubMed Scopus (147) Google Scholar Mechanistically, decorin engages vascular endothelial growth factor 2 (VEGFR2) for Peg3 redistribution on the autophagosomal membrane, concomitant with autophagosome formation in contrast to control conditions (Figure 1, A and B). Paramount with these observations is the requirement of Peg3 in maintaining basal BECN1 levels. Further, silencing Peg3 abrogates decorin-mediated induction of autophagic genes downstream of VEGFR221Buraschi S. Neill T. Goyal A. Poluzzi C. Smythies J. Owens R.T. Schaefer L. Torres A.T. Iozzo R.V. Decorin causes autophagy in endothelial cells via Peg3.Proc Natl Acad Sci U S A. 2013; 110: E2582-E2591Crossref PubMed Scopus (147) Google Scholar (Figure 2). Concurrently, mitochondrial membrane potential and capillary morphogenesis are disrupted.21Buraschi S. Neill T. Goyal A. Poluzzi C. Smythies J. Owens R.T. Schaefer L. Torres A.T. Iozzo R.V. Decorin causes autophagy in endothelial cells via Peg3.Proc Natl Acad Sci U S A. 2013; 110: E2582-E2591Crossref PubMed Scopus (147) Google ScholarFigure 2Categorically, the regulatory matrix entities segregate into two functionally distinct classes, activators (decorin, collagen VI, kringle 5, and endostatin) and inhibitor (laminin α2). Binding of each discrete molecule to a cognate receptor permits a multitude of signaling cascades that terminate on shared autophagic components. Cell- and tissue-specific modulation of this common core (Peg3, beclin 1, and LC3) ultimately dictates a pro- or anti-autophagic response. Please see text, where indicated, for complete pathway analyses. P-APMK, phosphorylated adenosine 5′-monophsophate-activated protein kinase.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Despite Peg3 being classified as a krupple-type zinc finger transcription factor, Peg3 is not observed within the nuclear compartment of endothelial cells, as shown for neural progenitors.22Relaix F. Weng X. Marazzi G. Yang E. Copeland N. Jenkins N. Spence S.E. Sassoon D. Pw1, a novel zinc finger gene implicated in the myogenic and neuronal lineages.Dev Biol. 1996; 177: 383-396Crossref PubMed Scopus (114) Google Scholar Because the architecture of zinc finger domains permits high-affinity RNA or DNA binding, Peg3 may bind mature BECN1 mRNA for protection, stability, and/or enhanced translation for rapid synthesis. This scenario is congruent with the rapid kinetics of decorin-evoked autophagic induction. Further, despite decorin inducing Peg3 expression in mammary fibroblasts cocultured with triple-negative breast carcinoma cells,20Buraschi S. Neill T. Owens R.T. Iniguez L.A. Purkins G. Vadigepalli R. Evans B. Schaefer L. Peiper S.C. Wang Z.X. Iozzo R.V. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.PLoS One. 2012; 7: e45559Crossref PubMed Scopus (73) Google Scholar transcriptional induction with macrovascular and microvascular endothelial cells is not achieved. Therefore, it remains plausible that decorin directly stabilizes Peg3 via as-of-yet defined post-translational modifications. Molecular dissection of the downstream signaling apparatus reveals that decorin rapidly activates AMP-activated protein kinase, a master energy sensor and pro-autophagic kinase,23Alers S. Löffler A.S. Wesselborg S. Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks.Mol Cell Biol. 2012; 32: 2-11Crossref PubMed Scopus (919) Google Scholar, 24Lee J.W. Park S. Takahashi Y. Wang H.G. The association of AMPK with ULK1 regulates autophagy.PLoS One. 2010; 5: e15394Crossref PubMed Scopus (378) Google Scholar downstream of VEGFR2 signaling25Goyal A. Neill T. Owens R.T. Schaefer L. Iozzo R.V. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.Matrix Biol. 2014; 34: 46-54Crossref PubMed Scopus (64) Google Scholar (Figure 2). Deciphering the complex regulatory network reveals that decorin suppresses anti-autophagic effectors (Akt, mTOR, p70S6K) while simultaneously evoking the physical and recombinatorial association of Bcl-2, beclin 1, and Vps3425Goyal A. Neill T. Owens R.T. Schaefer L. Iozzo R.V. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.Matrix Biol. 2014; 34: 46-54Crossref PubMed Scopus (64) Google Scholar Decorin-induced association of beclin 1/Vps34 complexes and the concurrent disengagement of the autophagic inhibitor Bcl-2 further reinforce a dynamic network for autophagic initiation that is wholly coordinated by an ECM constituent.25Goyal A. Neill T. Owens R.T. Schaefer L. Iozzo R.V. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.Matrix Biol. 2014; 34: 46-54Crossref PubMed Scopus (64) Google Scholar These findings reveal a new function for decorin. Because decorin requires the VEGFR2 kinase for downstream autophagic induction, the view of decorin as strictly an RTK inhibitor erodes; decorin does indeed function as a partial agonist of VEGFR2 and a modulator of a novel master regulator of autophagy, Peg3, which controls beclin 1 and LC3 expression. Decorin has an avid proclivity for attenuating epidermal growth factor receptor (EGFR) and downstream effectors. Notably, a recent study indicates that EGFR and Akt phosphorylate beclin 1, inactivating autophagic progression and promoting tumorigenesis.26Wei Y. Zou Z. Becker N. Anderson M. Sumpter R. Xiao G. Kinch L. Koduru P. Christudass C.S. Veltri R.W. Grishin N.V. Peyton M. Minna J. Bhagat G. Levine B. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.Cell. 2013; 154: 1269-1284Abstract Full Text Full Text PDF PubMed Scopus (396) Google Scholar, 27Wang R.C. Wei Y. An Z. Zou Z. Xiao G. Bhagat G. White M. Reichelt J. Levine B. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation.Science. 2012; 338: 956-959Crossref PubMed Scopus (538) Google Scholar Attenuation of EGFR and Akt signaling by decorin28Morrione A. Neill T. Iozzo R.V. Dichotomy of decorin activity on the insulin-like growth factor-I system.FEBS J. 2013; 280: 2138-2149Crossref PubMed Scopus (49) Google Scholar represents a viable signaling pathway for autophagic induction in cancer cells. Decorin exerts its anti-oncogenic activities indirectly via endothelial autophagy and directly by attenuating the angiogenicity of the tumor proper. Moreover, decorin functions as a partial agonist of Met and evokes tumor cell mitophagy in mammary carcinoma cells.29Neill T. Torres A. Buraschi S. Owens R.T. Hoek J. Baffa R. Iozzo R.V. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.J Biol Chem. 2014; 289: 4952-4968Crossref PubMed Scopus (65) Google Scholar By dynamically regulating peroxisome proliferator-activated receptor-γ coactivator-1α, stabilized mitostatin mRNA permits accumulated mitostatin and mitophagic induction independent of beclin 1 (Figure 2).29Neill T. Torres A. Buraschi S. Owens R.T. Hoek J. Baffa R. Iozzo R.V. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.J Biol Chem. 2014; 289: 4952-4968Crossref PubMed Scopus (65) Google Scholar Crucially, loss of mitostatin abrogates canonical mitophagic stimuli (rapamycin and nutrient deprivation) and decorin-evoked mitophagy.29Neill T. Torres A. Buraschi S. Owens R.T. Hoek J. Baffa R. Iozzo R.V. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.J Biol Chem. 2014; 289: 4952-4968Crossref PubMed Scopus (65) Google Scholar These observations define mitostatin as a novel and fundamental mitophagic effector. Importantly, failure of mitophagic induction prevents decorin from suppressing vascular endothelial growth factor A–mediated angiogenesis. Thus, mitostatin (and mitophagic initiation) is critical for decorin-mediated angiostasis.29Neill T. Torres A. Buraschi S. Owens R.T. Hoek J. Baffa R. Iozzo R.V. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.J Biol Chem. 2014; 289: 4952-4968Crossref PubMed Scopus (65) Google Scholar Autophagic induction may represent a general phenomenon for related SLRP members. Decorin may represent a novel class of matrix components that are released for autophagic induction after a pathological insult. A recent study indicates that FoxD1 transcriptionally represses Dcn expression.30Fetting J.L. Guay J.A. Karolak M.J. Iozzo R.V. Adams D.C. Maridas D.E. Brown A.C. Oxburgh L. FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney.Development. 2014; 141: 17-27Crossref PubMed Scopus (105) Google Scholar Derepression of Dcn via inactivation of FoxD1 would stimulate pro-autophagic processes mediated by decorin. FoxD1 may be downstream of anti-autophagic PI3K/Akt/mTOR effectors, or may be directly antagonized by the pro-autophagic AMP-activated protein kinase pathway. Thus, soluble decorin elicits autophagy within the stroma and mitophagy within the tumor and is postulated as a soluble factor for tumorigenic and angiogenic suppression. The role of autophagy in modulating tumorigenesis currently subsumes a dichotomous function by either promoting or restricting progression, although the precise function of autophagy in cancer remains unknown.31Hu Y.L. Jahangiri A. Delay M. Aghi M.K. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.Cancer Res. 2012; 72: 4294-4299Crossref PubMed Scopus (144) Google Scholar However, the critical importance of autophagy operating within the initial stages of tumorigenic development is rapidly becoming evident.32Kondo Y. Kanzawa T. Sawaya R. Kondo S. The role of autophagy in cancer development and response to therapy.Nat Rev Cancer. 2005; 5: 726-734Crossref PubMed Scopus (1460) Google Scholar Data support the existence of a common core of signaling pathways that are responsible for regulating cell proliferation, angiogenesis, cell growth, and apoptosis that are subverted for controlling autophagy throughout malignant transformation.32Kondo Y. Kanzawa T. Sawaya R. Kondo S. The role of autophagy in cancer development and response to therapy.Nat Rev Cancer. 2005; 5: 726-734Crossref PubMed Scopus (1460) Google Scholar Several opportunities for clinical intervention and novel chemotherapeutic targets (eg, mTOR, tuberous sclerosis 2, beclin 1) for modulating autophagy have come into focus.32Kondo Y. Kanzawa T. Sawaya R. Kondo S. The role of autophagy in cancer development and response to therapy.Nat Rev Cancer. 2005; 5: 726-734Crossref PubMed Scopus (1460) Google Scholar Hyperactive PI3K/Akt/mTOR/p70S6K signaling with the consequent activation of Ras via a class I PI3K typifies many solid tumors, including breast, lung, liver, and prostate carcinomas.31Hu Y.L. Jahangiri A. Delay M. Aghi M.K. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.Cancer Res. 2012; 72: 4294-4299Crossref PubMed Scopus (144) Google Scholar Collectively, the above signaling cascades inhibit autophagic progression and function while simultaneously driving cancer in a growth factor–dependent manner.32Kondo Y. Kanzawa T. Sawaya R. Kondo S. The role of autophagy in cancer development and response to therapy.Nat Rev Cancer. 2005; 5: 726-734Crossref PubMed Scopus (1460) Google Scholar Moreover, the down-regulation of autophagy (and to a larger extent, specialized autophagy, such as chaperone mediated and mitophagy) is associated with and considered necessary for competent tumorigenesis.31Hu Y.L. Jahangiri A. Delay M. Aghi M.K. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.Cancer Res. 2012; 72: 4294-4299Crossref PubMed Scopus (144) Google Scholar Metabolically, the stimulation of proliferation, migration, and metastasis strictly relies on various anabolic processes for macromolecule assembly. Conversely, as a whole, autophagy is a catabolic process that seemingly opposes molecular and biochemical synthesis.32Kondo Y. Kanzawa T. Sawaya R. Kondo S. The role of autophagy in cancer development and response to therapy.Nat Rev Cancer. 2005; 5: 726-734Crossref PubMed Scopus (1460) Google Scholar Furthermore, in the context of growth factor signaling, stimulatory ligands regulate glucose and amino acid influx and production, respectively, both of which are potent autophagic inhibitors.33Botti J. Djavaheri-Mergny M. Pilatte Y. Codogno P. Autophagy signaling and the cogwheels of cancer.Autophagy. 2006; 2: 67-73PubMed Google Scholar Stimulation of autophagy compromises several aspects of continued tumorigenic growth such as immune-evasion and angiogenesis.33Botti J. Djavaheri-Mergny M. Pilatte Y. Codogno P. Autophagy signaling and the cogwheels of cancer.Autophagy. 2006; 2: 67-73PubMed Google Scholar Intriguingly, specific classes of antineoplastic chemotherapeutics (eg, anthracyclines and oxaliplatin) trigger immunogenic cell death.34Michaud M. Martins I. Sukkurwala A.Q. Adjemian S. Ma Y. Pellegatti P. Shen S. Kepp O. Scoazec M. Mignot G. Rello-Varona S. Tailler M. Menger L. Vacchelli E. Galluzzi L. Ghiringhelli F. di Virgilio F. Zitvogel L. Kroemer G. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.Science. 2011; 334: 1573-1577Crossref PubMed Scopus (972) Google Scholar Importantly, these drugs require and depend on autophagic induction.34Michaud M. Martins I. Sukkurwala A.Q. Adjemian S. Ma Y. Pellegatti P. Shen S. Kepp O. Scoazec M. Mignot G. Rello-Varona S. Tailler M. Menger L. Vacchelli E. Galluzzi L. Ghiringhelli F. di Virgilio F. Zitvogel L. Kroemer G. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.Science. 2011; 334: 1573-1577Crossref PubMed Scopus (972) Google Scholar Tumors experiencing autophagy recruit T lymphocytes and antigen-presenting dendritic cells directly into the tumor parenchyma.34Michaud M. Martins I. Sukkurwala A.Q. Adjemian S. Ma Y. Pellegatti P. Shen S. Kepp O. Scoazec M. Mignot G. Rello-Varona S. Tailler M. Menger L. Vacchelli E. Galluzzi L. Ghiringhelli F. di Virgilio F. Zitvogel L. Kroemer G. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.Science. 2011; 334: 1573-1577Crossref PubMed Scopus (972) Google Scholar Moreover, pharmacological agents that suppress the anti-autophagic mTOR signaling cascade (eg, rapamycin) suppresses angiogenesis in various mouse models.33Botti J. Djavaheri-Mergny M. Pilatte Y. Codogno P. Autophagy signaling and the cogwheels of cancer.Autophagy. 2006; 2: 67-73PubMed Google Scholar Autophagic induction is directly relevant for chemotherapeutic efficacy and tumor responsiveness.31Hu Y.L. Jahangiri A. Delay M. Aghi M.K. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.Cancer Res. 2012; 72: 4294-4299Crossref PubMed Scopus (144) Google Scholar, 35Gewirtz D.A. The four faces of autophagy: implications for cancer therapy.Cancer Res. 2014; 74: 647-651Crossref PubMed Scopus (309) Google Scholar However, predictions for patient response to cancer therapeutics are compounded by our limited knowledge on forecasting autophagic flux in vivo in response to the stimulus.35Gewirtz D.A. The four faces of autophagy: implications for cancer therapy.Cancer Res. 2014; 74: 647-651Crossref PubMed Scopus (309) Google Scholar As such, four distinct forms of autophagy have been identified, cytoprotective, cytostatic, cytotoxic, and nonprotective,35Gewirtz D.A. The four faces of autophagy: implications for cancer therapy.Cancer Res. 2014; 74: 647-651Crossref PubMed Scopus (309) Google Scholar each offering unique cellular viability responses to chemotherapeutic agents. ECM molecules that function as autophagic inducers counteract growth factor signaling and suppress anti-autophagic signaling relays in favor of pro-autophagic outcomes (via Vps34). Intriguingly, decorin suppresses class I PI3K/mTOR signaling in physiologically normal endothelial cells, leading to autophagic programs.21Buraschi S. Neill T. Goyal A. Poluzzi C. Smythies J. Owens R.T. Schaefer L. Torres A.T. Iozzo R.V. Decorin causes autophagy in endothelial cells via Peg3.Proc Natl Acad Sci U S A. 2013; 110: E2582-E2591Crossref PubMed Scopus (147) Google Scholar Moreover, decorin elicits mitophagy in tumor cells.29Neill T. Torres A. Buraschi S. Owens R.T. Hoek J. Baffa R. Iozzo R.V. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.J Biol Chem. 2014; 289: 4952-4968Crossref PubMed Scopus (65) Google Scholar Collectively, induction by decorin (and related autophagic matrikines) may represent a